| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |